Legal & General Group PLC Catalyst Biosciences, Inc. Transaction History

Legal & General Group PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$4.1 - $5.33 $11,143 - $14,486	-2,718 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$4.93 - $7.15 $3,308 - $4,797	671 Added 32.78%	2,718 $14,000
Q3 2020 Nov 13, 2020	SELL	$4.22 - $6.04 $586 - $839	-139 Reduced 6.36%	2,047 $9,000
Q2 2020 Aug 14, 2020	BUY	$3.76 - $8.01 $8,219 - $17,509	2,186 New	2,186 $13,000
Q3 2019 Nov 13, 2019	SELL	$4.91 - $9.31 $8,700 - $16,497	-1,772 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$9.11 - $28.88 $16,142 - $51,175	1,772 New	1,772 $21,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.